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Abstract objective To assess follow-up and programmatic outcomes of HIV-exposed infants at Martin
Preuss Centre, Lilongwe, from 2012 to 2014.
methods Retrospective cohort study using routinely collected HIV-exposed infant data. Data were
analysed using frequencies and percentages in Stata v.13.
results Of 1035 HIV-exposed infants registered 2012–2014, 79% were available to be tested for
HIV and 76% were HIV-tested either with DNA-PCR or rapid HIV test serology by 24 months of
age. Sixty-five infants were found to be HIV-positive and 43% were started on antiretroviral therapy
(ART) at different ages from 6 weeks to 24 months. Overall, 48% of HIV-exposed infants were
declared lost-to-follow-up in the database. Of these, 69% were listed for tracing; of these, 78% were
confirmed as lost-to-follow-up through patient charts; of these, 51% were traced; and of these, 62%
were truly not in care, the remainder being wrongly classified. Commonest reasons for being truly not
in care were mother/guardian unavailability to bring infants to Martin Preuss Centre, forgetting clinic
appointments and transport expenses. Of these 86 patients, 36% were successfully brought back to
care and 64% remained lost-to-follow-up.
conclusion Loss to follow-up remains a huge challenge in the care of HIV-exposed infants. Active
tracing facilitates the return of some of these infants to care. However, programmatic data
documentation must be urgently improved to better follow-up and link HIV-positive children to
ART.
keywords HIV-exposed children, HIV, antiretroviral therapy, back-to-care programme, Malawi
Introduction
Since the global scale up of antiretroviral therapy (ART)
in 2003, the enrolment of HIV-infected women to HIV
care and treatment services has steadily increased in
sub-Saharan African settings. The use of ART in HIV-
infected pregnant and lactating women prevents mother-
to-child transmission (PMTCT) of HIV, improves moth-
ers’ health and prevents HIV transmission to spouses
[1–3]. The success of any PMTCT programme requires
careful and rigorous management and follow-up of
HIV-exposed infants and their mothers, and retention in
care is an enormous challenge in many resource-poor
countries [4, 5].
Since AIDS was first recognised in Malawi in 1985, the
country has suffered from a dire HIV and AIDS epidemic.
In 2010, Malawi had an HIV prevalence of 11% in the
whole population [6]. In July 2011, the country proposed
and adopted the Option B+ approach to PMTCT, a pol-
icy whereby all HIV-infected pregnant and breastfeeding
women are started on combination ART for life, regard-
less of their WHO clinical stage and/or CD4 cell count
[7, 8]. This strategy was endorsed in a further revision of
the Malawi’s national integrated ART/PMTCT guidelines
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in 2014 [9]. Also, the 2013 WHO guidance on HIV and
AIDS adopted the Option B+ PMTCT approach and
completely dropped the Option A PMTCT approach as
reflected in the 2015 WHO Global ART/PMTCT guide-
lines. While several studies have reported programme
outcomes among HIV-positive women taking the
PMTCT approach [10–12], there are few studies on out-
comes of HIV-exposed infants [12].
In a rural district of Malawi, retention in care of HIV-
exposed infants was reasonable at 70% but <20% of
children were HIV-tested, either through DNA-PCR or
HIV serology [13]. Another study conducted at the Pri-
mary Health Care Level in Malawi also demonstrated
that up to one-third of HIV-exposed infants failed to
complete the early infant HIV diagnosis (EID) services
because of time and costs required for multiple visits, and
lack of awareness of the infants’ fathers about their child
being HIV-tested [14]. While tracing outcomes amongst
women enrolled in Lilongwe’s PMTCT Option B+ pro-
gramme have previously been analysed [15, 16], there is
no published information on the treatment and tracing
outcomes of HIV-exposed infants at the Martin Preuss
Centre (MPC) clinic. Such information would be useful
for the follow-up and management of HIV-exposed
infants at MPC and other similar settings. We therefore
assessed the follow-up and treatment outcomes of HIV-
exposed infants who were receiving HIV care from MPC
clinic between January 2012 and December 2014. The
specific objectives were to determine: (i) the cumulative
number of HIV-exposed infants registered during the
3 years and their baseline characteristics, (ii) HIV testing
uptake, HIV-positive results and initiation of ART at var-
ious ages, and (iii) cumulative programmatic outcomes,
losses to follow-up and their reasons and the outcomes of
tracing back to care.
Methods
Study design
This was a retrospective cohort study using routinely col-
lected data.
General setting
Malawi is a sub-Saharan African country with a popula-
tion of approximately 17 million and an estimated Gross
National Income per capita of USD 730 [17]. Health care
is provided free of charge in the public sector for the
whole country for all diseases. In 2012, the life expec-
tancy was 59 years, the under-five mortality rate was 71
per 1000 live births and the maternal mortality ratio was
510 per 100 000 live births [17]. Death due to HIV was
estimated at 287 per 100 000 [17].
HIV/AIDS management
The Malawi National HIV treatment programme was ini-
tiated in 2004. Since then, the country has been providing
ART to the HIV-infected population with no patient fees
at the health facility. HIV diagnosis and care are decen-
tralised in the whole country. Most health facilities incor-
porate provider-initiated HIV testing and counselling.
The national guidelines for clinical management of HIV
stress the need for active follow-up for both HIV-infected
persons and HIV-exposed infants [8, 9]. However, in rou-
tine practice, there is either no or minimal active follow-
up of HIV-infected adults, children or exposed infants
once they have discontinued their HIV care because of
facility or individual level reasons.
Study setting
The Lighthouse Trust is a registered public trust that con-
tributes to Malawi’s national response to HIV. It is a
Centre of Excellence for the provision of a continuum of
high quality care and builds capacity of other facilities in
the health sector. The Lighthouse Trust operates two
large integrated HIV testing, treatment and care clinics in
Lilongwe, Malawi: the Lighthouse clinic situated in the
campus of Kamuzu Central Hospital (KCH) and the
MPC clinic in the campus of Bwaila Hospital under the
authority of the Lilongwe District Health Office. At these
clinics, the Lighthouse Trust directly provides HIV testing
services (HTS), facility-based clinical services, and com-
munity-based health services. MPC is an integrated TB/
HIV clinic, managed under the partnership of Lighthouse
and the Lilongwe District Hospital, with units that are
responsible for HTS, provision of ART and management
of integrated initiatives such as sexual and reproductive
health services, screening and management of hyperten-
sion and tuberculosis.
According to Malawi national ART/PMTCT guideli-
nes, HIV-exposed infants should be registered into the
early infant diagnosis (EID) program soon after birth and
clinic follow-up starts 6 weeks after delivery. During reg-
istration, infants’ guardians are asked for consent to trace
them in the event that their infants fail to come to the
clinic on scheduled clinic appointments for at least
56 days. Providers are encouraged to synchronise the
appointments of both mother and infant [Mother Infant
Pair (MIP)], so that they can be reviewed on the same
day. Infants are followed up monthly up to 24 months.
DNA-PCR testing is performed at the start of follow-up
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(at 6 weeks of age or within a range of 4–8 weeks) and
the HIV rapid serological test (using Determine and Uni-
Gold) is done at 12 months and 24 months of age [8, 9].
Newly HIV-diagnosed infants are immediately started on
ART while HIV-negative infants at the age of 24 months
or 6 weeks after cessation of breast feeding are dis-
charged from care. Registration and follow-up informa-
tion were recorded in a paper treatment card and later
entered into a customised Microsoft Access database.
Back-to-care (B2C) programme
The Malawi National ART/PMTCT guidelines for clini-
cal management of HIV stress the need for active follow-
up for both HIV-infected persons and HIV-exposed
infants [8, 9]. However, in routine practice, there is either
no or minimal active follow-up of HIV-infected adults,
children or exposed infants once they have discontinued
their HIV care because of facility or individual level rea-
sons. In the event of mother and/or infants missing their
follow-up appointment for at least 2 months after their
scheduled appointment, and if they have previously con-
sented, they are traced by the B2C staff using various
tracing modalities.
The B2C programme, which started in 2006 with fund-
ing from International Epidemiologic Database to Evalu-
ate AIDS in Southern Africa (IeDEA-SA) [16], employs
six persons who are all trained lay-workers. The aim of
the B2C programme is to improve patient retention at
Lighthouse clinics [16]. The tracers use three modalities
of tracing: sending short messaging services (SMS) on
mobile phones, making voice phone calls and going on
field visits to clients’ homes or other preferred locations.
If patients have a mobile phone, standardised text mes-
sages are sent reminding them to come back to care or to
contact the B2C staff. After 2 days, if they still have not
come to the clinic or made further communication with
the clinic staff, voice calls are made on their phones. If
the phone calls are unsuccessful, either because the
patient cannot be reached or the patient still does not
come back to the clinic, then trained field tracers make a
field visit.
In order to trace HIV-exposed infants who are lost-
to-follow-up, a list of HIV-exposed infants who missed
their scheduled clinic appointments by at least 56 days is
generated using HIV-exposed infant follow-up data
which is entered in the Microsoft Access database. The
outcome of lost-to-follow-up in the electronic database is
then confirmed against treatment cards or files. A B2C
staff member fills in the demographics section of the trac-
ing form using information in the patient chart. The data
sources for this information are the HIV-exposed infant
master card and the patient locator form. The locator
form contains details about how the children and their
guardians can be reached and includes a sketch of the
patient’s geographical location on a map.
Study population
All HIV-exposed infants who were registered in the EID
programme at MPC between January 2012 and Decem-
ber 2014 were included in the study.
Data variables, sources of data, data collection tools and
data validation
The data variables included: year of registration; infant
age; infant sex; mother’s ART status; infant breast feed-
ing status; documented guardian; agreement or not by
the guardian to have the infant actively followed up in
case of non-attendance at clinic; for the infants and chil-
dren – HIV testing by DNA or HIV rapid serology; HIV-
positive status; ART initiation; cumulative programmatic
outcomes by 30 June, 2015; for children lost-to-follow-
up (defined as an HIV-exposed infant who did not come
for review for at least 56 days after the scheduled clinic
appointment) – HIV-exposed infants listed for tracing;
tracing carried out; true outcomes of those traced; and
for those not in care, the reasons for not being in care.
The sources of data were the customised Microsoft
Access database for the HIV-exposed infants, the HIV-
exposed infant treatment cards, patient files and the trac-
ing forms. Data entry clerks were trained to update the
Microsoft Access database routinely. After tracing, data
were entered, random checks were made on every twenti-
eth tracing form to assure data entry quality.
Statistical analysis
Data were transferred from the Microsoft Access to
STATA 13.0 (Stata Corp., College Station, TX). Data
were analysed using frequencies and percentages. The
STrengthening the Reporting of OBservational studies in
Epidemiology (STROBE) guidelines were used to conduct
and report on the findings of this study [18].
Ethics
The study was approved by the Malawi National Health
Science Research Committee in Lilongwe, Malawi (proto-
col #:822). The study met the Medecins Sans Frontieres
(MSF) Ethics Review Board (Geneva, Switzerland)
approved criteria for studies of routinely collected data
and was also approved by the Ethics Advisory Group of
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the International Union Against Tuberculosis and Lung
Disease, Paris, France. As this was a record review study
with anonymised data, the issue of informed patient con-
sent did not apply.
Results
Baseline characteristics of HIV-exposed infants
There were 1035 HIV-exposed infants registered at MPC
over the 3 years, with a median interquartile range
(IQR) age at registration of 32 weeks (10–59 weeks).
Baseline characteristics are shown in Table 1. There were
increasing numbers of children registered each year from
2012 to 2014. In those with documentation, key findings
were that the majority of infants were registered after
6 weeks of age, most mothers were alive and on ART,
mixed feeding was the predominant method and in most
cases the guardian of the child was the mother. The
majority of guardians agreed that they and their infants
could be actively followed up in case of non-attendance
at MPC. For all individual field categories, there were
missing data ranging from 2% to 36%.
HIV testing, HIV-positive results and initiation of ART
Cumulative numbers of children HIV tested, found to be
HIV-positive and started on ART at various ages are
shown in Table 2. Of the 1035 infants, 79% were avail-
able to be tested for HIV and 76% were HIV-tested
either with DNA-PCR or rapid HIV test serology by
24 months of age. By 6 weeks of age, 5% of infants
tested were HIV-infected. From 6 months to 24 months
of age, the proportion found to be HIV-infected was 8%.
Of the 65 infants found to be HIV-positive, 43% were
started on ART at different ages from 6 weeks to
24 months.
Programme outcomes of early infant diagnosis and
outcomes of tracing through back-to-care programme
The cumulative programmatic outcomes of children in the
3-year cohort censored on 30 June, 2015, are shown in
Table 3. Altogether, there were 385 (37%) children who
had either completed their 24-month care and were dis-
charged HIV-negative to the community or were still
retained in care, on or off ART. Of all the children, 48%
were declared lost-to-follow-up in the database. Of the
remainder, 67 (7%) were transferred to another clinic with
their current status unknown, six children were known to
have died and in 76 (7%) there was no documentation of
outcome.
Of the 501 children declared lost-to-follow-up in the
electronic database, 69% were listed for tracing, 271
(78%) of these had confirmation from patient records
that they were indeed lost-to-follow-up and 138 (51%)
of these were actively followed up by tracing (Table 4).
Of the 138 who were traced by SMS, phone calls or
home visits, 62% were not in care with the remainder
misclassified. The actual outcomes of the misclassified
HIV-exposed infants were transferred out, discharged
HIV-negative from the clinic, still in care or had died. Of
those not in care, the three commonest documented rea-
sons were the mother or guardian not regularly available
to bring the infant to MPC, the expense of transport
from home to MPC and back, and mothers and
guardians regularly forgetting the appointment dates. Of
these 86 patients who were not in care, 36% were
successfully brought back to care and 64% remained
lost-to-follow-up.
Table 1 Baseline characteristics of HIV-exposed infants regis-
tered at Martin Preuss Centre, Lilongwe, Malawi: 2012–2014
Baseline characteristics n (%)
All children 1035 (100)
Year of Registration of the child
2012 263 (25)
2013 346 (34)
2014 426 (41)
Gender
Male 536 (52)
Female 477 (46)
Not documented 22 (2)
Age in weeks at time of registration
<6 weeks 142 (14)
6 weeks or more 844 (81)
Not documented 49 (5)
Mother’s status at time of registration
Alive on ART 606 (59)
Alive not on ART 46 (4)
Dead 14 (1)
Not documented 369 (36)
Infant breast feeding status
Exclusive breast feeding 441 (43)
Mixed feeding 514 (50)
Stopped breast feeding before registration 42 (4)
Not documented 38 (3)
Infant’s selected guardian
Mother 709 (68)
Another person 3 (<1)
Not documented 323 (31)
Agreed to active follow-up in case of not attending the clinic
Yes 871 (84)
No 12 (1)
Not documented 152 (15)
ART, antiretroviral therapy.
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Discussion
This study examined the outcomes of a large cohort of
HIV-exposed infants at MPC in Lilongwe where the
number of HIV-exposed infants was substantial and
increasing year by year. There were a number of impor-
tant findings. First, while a substantial proportion of
infants and children were HIV tested, <20% received an
appropriate HIV test (DNA-PCR) at 6 weeks of age
mainly because children were enrolled too late into the
programme. This is a missed opportunity for preventing
infection and starting ART early in life. Furthermore,
according to the records, <50% of the children who were
diagnosed HIV-positive between 6 weeks and 24 months
of age were initiated on ART, so missed opportunities
are being perpetuated. Second, retention in care was poor
with nearly half of all infants being recorded in the data-
base as lost-to-follow-up. However, when the B2C pro-
gramme was implemented, there were many gaps and
mistakes observed in the documentation of routine ser-
vice delivery and loss to follow-up of infants. The tracing
lists were incomplete, the confirmation of ‘lost-to-follow-
up’ was incorrect when checked against cards and files
and about 40% of the children who had been declared
lost-to-follow-up after this checking had been done actu-
ally had a different outcome when traced by phone or
field visits. Thus, the actual loss to follow-up was smaller
than that recorded in the database. Third, the main docu-
mented reasons for infants not being in care were moth-
ers or guardians forgetting or not being available for the
clinic appointments as well as transport expenses. Finally,
tracing was successful in bringing a third of the children
who were documented as not in care back to MPC for
follow-up. However, this is still less than the overall B2C
success rate for patients on ART which is at around two-
thirds [16].
The strengths of this study were the large sample size
and its conduct within the routine service delivery setting,
which potentially allows the data to improve operational
practice and inform policy change. We also adhered to
the STROBE guidelines for conducting and reporting on
observational studies [18]. The major weakness was miss-
ing or incorrect data. Some of the baseline characteristics
were missing in up to one-third of infants and the tracing
lists, which are so important to activate tracing activities,
did not capture all patients declared lost-to-follow-up in
the database. Where tracing lists were produced, they
were quite frequently wrong when checked against cards
and files. Finally, sizable numbers of children being
traced in fact were in care, had been discharged HIV-
negative from MPC or had transferred out from the
clinic.
Table 2 HIV-exposed infants registered at Martin Preuss Centre, Lilongwe, Malawi, from 2012 to 2014 who were cumulatively HIV
tested, found HIV-positive and started on antiretroviral therapy at specific ages
Age of the child
Available to be HIV-tested* HIV-tested (DNA-PCR or serology) Diagnosed HIV-positive Started on ART
n† n (%)‡ n (%)§ n (%)¶
Up to 6 weeks 197 175 (89) 8 (5) 3 (38)
Up to 6 months 431 379 (88) 30 (8) 11 (37)
Up to 12 months 625 567 (91) 47 (8) 18 (38)
Up to 18 months 779 717 (92) 54 (8) 22 (41)
Up to 24 months 814 785 (96) 65 (8) 28 (43)
ART, antiretroviral therapy.
*DNA PCR is supposed to be performed at 6 weeks (with a range of 4–8 weeks) and HIV rapid test serology is supposed to be per-
formed at 12-months and at 24-months. A positive DNA PCR result is indicative of HIV-infection at any time from 4 weeks of age. A
positive HIV serology result is indicative of HIV-infection only from 12-months of age or later.
†The numbers eligible for testing are cumulative.
‡Percentage is determined by: HIV-testing divided by eligible to be tested.
§Percentage is determined by: HIV-positive divided by HIV tested.
¶Percentage is determined by: Started ART divided by HIV-positive.
Table 3 Cumulative programmatic outcomes before tracing of
HIV-exposed infants who were registered at Martin Preuss Cen-
tre, Lilongwe, Malawi between 2012–2014: with outcome data
censored on 30 June, 2015
HIV-exposed children n (%)
Total registered for care 1035 (100)
Formally discharged HIV-negative from care 207 (20)
Retained in care (including being on ART) 178 (17)
Lost-to-follow-up 501 (48)
Transferred out to another center 67 (7)
Died 6 (1)
No documentation 76 (7)
ART, antiretroviral therapy.
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Regardless of the challenges with the Lilongwe B2C
programme, there is an urgent need to improve on the
follow-up of HIV-exposed infants in high HIV-burden
countries and ensure that they are HIV-tested in a timely
and appropriate way and are referred to care and
treatment. This is not an easy task. In a recent study in
five districts of central Malawi assessing the impact of
Option B+, documentation of baseline characteristics and
follow-up parameters of HIV-exposed infants was poor
at 27%, with only 20% of infants having EID performed;
and median age of testing varied from 10 to 16 weeks
[19]. Similar to our study, other recent studies from
Mozambique [20], Nigeria [21], Tanzania [22] and the
Democratic Republic of the Congo [23] have found large
losses to follow-up in HIV-exposed infants, especially in
relation to EID, where similar to the findings of our study
infants also often come late for testing [20]. Ways to
reduce losses to follow-up need to be found. Studies have
identified various risk factors for high losses to follow-up
such as poverty, distance from health facilities, lack of
paternal support, little formal education of the guardian,
a long duration between scheduled appointments and
having a female child [4, 5]. Some of these factors, such
as poverty, are difficult to influence, but attention to cor-
recting those that are amenable to change might improve
retention in care. Having a mother on ART is associated
with a significant reduction in loss to follow-up vs. not
having a mother on ART [24], and thus efforts to ensure
linkage of testing with treatment in the Option B+ pro-
gramme are likely to reduce losses to follow-up amongst
HIV-exposed children. Male involvement in a variety of
PMTCT interventions has been shown to reduce loss to
follow-up [25]. Good documentation and management of
patient records, accompanied with active tracing and fol-
low-up of patients has been reducing losses to follow-up,
improving retention in care and HIV testing uptake [16,
26].
There are therefore some important practical implica-
tions arising from this study for facilities that are similar
to MPC with regard to context and resource. First, docu-
mentation at MPC needs to improve as currently the
database is over-reporting the loss to follow-up. This will
require a more pro-active and systematic approach to
supervision and checking of the current database from
cards and patient files and ensuring that the electronic
database comprehensively captures and links all compo-
nents of PMTCT.
Second, more concerted efforts are needed to enrol
HIV-exposed infants into the MPC programme before or
at 6 weeks of age so that DNA-PCR testing can be done
in a timely way, and subsequently the infants confirmed
to be HIV-infected should start ART immediately as per
national and international guidelines [2, 8, 9]. A point of
care test (not necessarily done at birth) would improve
testing rates and perhaps retention in care [27].
Finally, given that about one-third of infants who were
not in care at the time of tracing were in fact brought
Table 4 True outcomes of HIV-exposed infants who were
declared lost-to-follow-up at Martin Preuss Centre, Lilongwe,
Malawi from 2012 to 2014: results from the back-to care pro-
gramme
Outcomes in children declared
lost-to-follow-up* n (%)
Declared lost-to-follow-up in the
electronic database
501 (100)
Line listed and in need of tracing and
follow-up†
346 (69)
Outcome ‘Lost-to-follow-up’ confirmed
through cards and patient files‡
271 (78)
Children traced by SMS messages, phone
calls or visits to their homes§
138 (51)
True outcomes of children who were traced
Not in care¶ 86 (62)
Transferred out and in care at another clinic 22 (16)
Discharged HIV-negative from the center 14 (10)
Currently still in care at MPC 13 (10)
Death 2 (2)
Tracing done but no documentation
of outcome
1 (<1)
Reasons for not being in care**
Mother or guardian not regularly
available to bring infant to center
21 (24)
Transport between home and center
too expensive
16 (19)
Mother/guardian regularly forgot
about appointment dates
13 (15)
Mother/guardian did not see the need
to bring HIV-negative infant to center
8 (9)
Infant too sick to be brought to center 1 (2)
No reasons provided 29 (31)
MPC, Martin Preuss Centre, Lilongwe, Malawi.
*Lost-to-follow-up is defined as no attendance at MPC 56 or
more days after the scheduled appointment date.
†There were 155 children who were lost-to-follow-up who did
not appear in the line list of those who needed to be traced.
‡There were 75 infants in the line list who were declared lost-to-
follow-up but on rechecking treatment cards and files it was dis-
covered that this was not so and was a clerical error of recording.
§There were 133 infants who could not be traced mainly because
their families had moved out of Lilongwe or the given address
was incorrect.
¶Of the 86 infants who were not in care at the time of tracing,
31 (36%) subsequently came back to care during the period of
the study.
**In one case there was more than one reason for not being in
care.
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back to follow-up, the B2C programme can be enhanced
with regard to human resources and other transportation
related needs. Doing so will enable such programmes to
strengthen facility level services and cover more areas in
their active tracing of children. The use of cell phone
SMS has been found useful in Africa for improving the
quality of care and follow-up of people with HIV/AIDS
[28, 29]. The B2C programme needs to consider using
SMS to remind guardians and mothers about scheduled
appointments and the need to adhere to medication in
addition to using this technology after infants have been
declared lost-to-follow-up. Transport expenses being high
were also mentioned as a reason for not being in care.
MPC needs to consider whether transport reimbursement,
which has been shown to improve retention in care [29],
can be supported and sustained.
In conclusion, large numbers of HIV-exposed infants
have been, and continue to be, enrolled for care at MPC.
While overall HIV testing uptake was better than else-
where in Malawi, loss to follow-up remains a major con-
cern. Active tracing of infants that are documented as
lost-to-follow-up brought some infants back to care.
However, significant improvement needs to be made par-
ticularly with respect to documentation of routine ser-
vices, linkage of HIV diagnosis to care and active follow-
up of those enrolled in care. With the international com-
munity signed up to end the epidemic of AIDS by 2030
[30], attention to interventions that focus on retention is
essential if this goal is to be realised.
Acknowledgements
This research was conducted through the Structured
Operational Research and Training Initiative (SORT IT),
a global partnership led by the Special Programme for
Research and Training in Tropical Diseases at the World
Health Organization (WHO/TDR). The model is based
on a course developed jointly by the International Union
Against Tuberculosis and Lung Disease (The Union) and
Medecins sans Frontieres. The specific SORT IT pro-
gramme which resulted in this publication was jointly
developed and implemented by: the Operational Research
Unit (LUXOR), Medecins Sans Frontieres, Brussels Oper-
ational Center, Luxembourg; the Centre for Operational
Research, The Union, Paris, France; the Centre for Inter-
national Health, University of Bergen, Norway; the Insti-
tute of Tropical Medicine, Antwerp, Belgium; and
Partners in Health, USA. The programme was funded by
The Union, MSF, and the Department for International
Development (DFID), UK. The funders had no role in
study design, data collection and analysis, decision to
publish, or preparation of the manuscript. La Fondation
Veuve Emile Metz-Tesch, Luxembourg also supported
open access publication costs.
References
1. World Health Organization. Programmatic Update. Use of
Antiretroviral Drugs for Treating Pregnant Women and
Preventing HIV Infection in Infants. WHO: Geneva,
Switzerland, 2012.
2. World Health Organization. Consolidated Guidelines on the
Use of Antiretroviral Drugs for Treating and Preventing
HIV Infection. Recommendations for a Public Health
Approach. WHO: Geneva, Switzerland, 2013.
3. Cohen MS, Chen YQ, McCauley M et al. Prevention of
HIV-1 infection with early antiretroviral therapy. N Engl J
Med 2011: 365: 493–505.
4. Jones SA, Sherman GG, Varga CA. Exploring socio-eco-
nomic conditions and poor follow-up rates of HIV-exposed
infants in Johannesburg, South Africa. AIDS Care 2015: 17:
466–470.
5. Bigna JJ, Noubiapo JJN, Plottel CS, Kouanfack C, Koulla-
Shiro S. Factors associated with non-adherence to scheduled
medical follow-up appointments among Cameroonian chil-
dren requiring HIV care: a case-control analysis of the
usual-care group in the MORE CARE trial. Infect Dis Pov-
erty 2014: 3: 44.
6. National Statistical Office. Malawi Demographic and Health
Survey (2011th edn), NSO-Malawi: Zomba, Malawi, 2010.
7. Schouten EJ, Jahn A, Midiani D et al. Prevention of
mother-to-child transmission of HIV and the health-related
Millennium Development Goals: time for a public health
approach. Lancet 2011: 378: 282–284.
8. Ministry of Health, Malawi. Clinical Management of HIV
in children and adults. Malawi Integrated Guidelines for
Providing HIV Services in: Antenatal Care; Maternity Care;
Under 5 Clinics; Family Planning Clinics; Exposed Infant/
Pre-ART Clinics; ART Clinics (1st edn), Ministry of Health:
Lilongwe, Malawi, 2011.
9. Ministry of Health, Malawi. Clinical Management of
HIV in Children and Adults. Ministry of Health:
Lilongwe, Malawi, 2014.
10. Tenthani L, Haas AD, Tweya H et al. Retention in care
under universal antiretroviral therapy for HIV-infected preg-
nant and breastfeeding women (‘Option B+’) in Malawi.
AIDS 2014: 28: 589–598.
11. Kamuyango AA, Hirschhorn LR, Wang W, Jansen P, Hoff-
man RM. One-year outcomes of women started on
antiretroviral therapy during pregnancy before and after the
implementation of Option B+ in Malawi: a retrospective
chart review. World J AIDS 2014: 4: 332–337.
12. Kim MH, Ahmed S, Hosseinipour MC et al. Implementation
and operational research: the impact of Option B+ on the
antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir
Immune Defic Syndr 2015: 68: e77–e83.
13. Perez GM, Metcalf C, Garone R et al. HIV testing and
retention in care of infants born to HIV infected women
© 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1001
Tropical Medicine and International Health volume 21 no 8 pp 995–1002 august 2016
W. F. Ng’ambi et al. Outcomes of HIV-exposed Malawian children
enrolled in “Option B+”, Thyolo, Malawi. Public Health
Action 2014: 4: 102–104.
14. Cromwell EA, Dow AE, Low D et al. Barriers to successful
early infant diagnosis of HIV infection at primary care level
in Malawi. Pediatr Infect Dis J 2015: 34: 273–275.
15. Tweya H, Gugsa S, Hosseinipour M et al. Understanding
factors, outcomes and reasons for loss to follow-up among
women in Option B+ PMTCT programme in Lilongwe,
Malawi. Trop Med Int Health 2014: 19: 1360–1366.
16. Tweya H, Gareta D, Chagwera F et al. Early active follow-
up of patients on antiretroviral therapy (ART) who are lost-
to-follow-up: the “Back-to-Care” project in Lilongwe,
Malawi. Trop Med Int Health 2010: 15(Suppl 1): 82–89.
17. World Health Organization. World Health Statistics. WHO:
Geneva, Switzerland, 2014.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche P,
Vandenbroucke JP, for the STROBE initiative. The strength-
ening the reporting of observational studies in epidemiology
(STROBE) statement: guidelines for reporting observational
studies. Lancet 2007: 370: 1453–1457.
19. Herce ME, Mtande T, Chimbwandira F et al. Supporting
Option B+ scale up and strengthening the prevention of
mother-to-child transmission cascade in central Malawi:
results from a serial cross-sectional study. BMC Infect Dis
2015: 15: 328.
20. Cook RE, Ciampa PJ, Sidat M et al. Predictors of successful
early infant diagnosis of HIV in a rural district hospital in
Zambezia, Mozambique. J Acquir Immune Defic Syndr
2011: 56: e104–e109.
21. Anoje C, Aiyenigba B, Suzuki C et al. Reducing mother-to-
child transmission of HIV: findings from an early infant
diagnosis program in south-south region of Nigeria. BMC
Public Health 2012: 12: 184.
22. Chiduo MG, Mmbando BP, Theilgaard ZP et al. Early
infant diagnosis of HIV in three regions in Tanzania; suc-
cesses and challenges. BMC Public Health 2013: 13: 910.
23. Feinstein L, Edmonds A, Chalachala JL et al. Temporal
changes in the outcomes of HIV-exposed infants in Kin-
shasa, Democratic Republic of Congo during a period of
rapidly evolving guidelines for care (2007–2013). AIDS
2014: 28(Suppl 3): S301–S311.
24. Feinstein L, Edmonds A, Okitolonda V et al. Implementa-
tion and operational research: maternal combination
antiretroviral therapy is associated with improved retention
of HIV-exposed infants in Kinshasa, Democratic Republic of
Congo. J Acquir Immune Defic Syndr 2015: 69: e93–e99.
25. Nyondo AL, Chimwaza AF, Muula AS. Exploring the rele-
vance of male involvement in the prevention of mother to
child transmission of HIV services in Blantyre, Malawi.
BMC Int Health Hum Rights 2014: 14: 30.
26. Ahmed I, Gugsa ST, Lemma S, Demissie M. Predictors of
loss to follow-up before HIV treatment initiation in North-
west Ethiopia: a case-control study. BMC Public Health
2013: 13: 867.
27. McCollum ED, Preidis GA, Maliwichi M et al. Clinical ver-
sus rapid molecular HIV diagnosis in hospitalized african
infants: a randomized controlled trial simulating point of-
care infant testing. J Acquir Immune Defic Syndr 2014: 66:
e23–e30.
28. Bahadur M, Murray PJ. Cell phone short messaging ser-
vice (SMS) for HIV/AIDS in South Africa: a literature
review. Stud Health Technol Inform 2010: 160(Pt 1): 530–
534.
29. Siedner MJ, Santorino D, Lankowski AJ et al. A combina-
tion SMS and transportation reimbursement intervention to
improve HIV care following abnormal CD4 test results in
rural Uganda: a prospective observational cohort study.
BMC Med 2015: 13: 160.
30. United Nations. Transforming our world: the 2030 agenda
for sustainable development, 2015. (Available from:
http://sustainabledevelopment.un.org/post2015/transformin-
gourworld) [25 Nov 2015].
Corresponding Author Wingston F. Ng’ambi, The Lighthouse Clinic, Kamuzu Central Hospital, Lilongwe, Malawi. Email:
wingston.ngambi@gmail.com
1002 © 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Tropical Medicine and International Health volume 21 no 8 pp 995–1002 august 2016
W. F. Ng’ambi et al. Outcomes of HIV-exposed Malawian children
